Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Portfolio > Portfolio Construction

Three Fund Managers Leave Fidelity

X
Your article was successfully shared with the contacts you provided.

Jan. 14, 2005 — Three fund managers are leaving Fidelity Investments, including Beso Sikharulidze, who oversaw the $9.1 billion Fidelity Mid Cap Stock (FMCSX).

Adam Segal and Ian Gutterman, who piloted Fidelity sector funds, are also stepping down. The three men are leaving to “pursue new opportunities,” and their departures are not related, a company spokesman said.

Shep Perkins succeeded Sikharulidze on the Mid Cap Stock fund. Perkins has been running the $8.1-million Fidelity OTC (FOCPX) since April 2003, and previously ran other Fidelity funds that invest in selected industries.

Steven Calhoun was named an associate portfolio manager of the Mid Cap Stock fund. Previously, he oversaw a stock portfolio for institutional investors.

Sonu Kalra replaced Perkins on the OTC fund. James Morrow succeeded Kalra on the $2.2-billion Fidelity Select Technology (FSPTX). Morrow continues to manage Fidelity Select Electronics (FSELX) and Fidelity Advisor Electronics/A (FELAX), which he took over in February 2004.

Yun-Min (Charlie) Chai replaced Kalra as manager of Fidelity Advisor Technology/A (FADTX). He and Kalra succeeded Kalra as leaders of the company’s technology equity research group. Chai continues to manage Fidelity Select Networking & Infrastructure (FNINX), Fidelity Select Developing Communications (FSDCX) and Fidelity Advisor Devel Communication/A (FDMAX).

Naved Khan replaced Kalra as portfolio manager of the $738-million Fidelity Select Computers (FDCPX). Khan, the former manager of Fidelity Select Natural Gas (FSNGX), recently began following technology companies as an analyst.

Gutterman was replaced on the $97-million Fidelity Select Pharmaceuticals (FPHAX) by Harlan Carere, who also runs Fidelity Select Biotechnology (FBIOX).

Martin Zinny, who had been an analyst following the retail industry, succeeded Segel on the $130-million Fidelity Select Retailing (FSRPX).

The changes in portfolio managers, which took effect on January 12, were posted on Fidelity’s Web site.

Contact Bob Keane with questions or comments at: [email protected].


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.